Review
Copyright ©The Author(s) 2021.
World J Diabetes. Jun 15, 2021; 12(6): 706-729
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.706
Table 1 Summary of meta-analyses evaluating risk of fracture in patients with type 2 diabetes mellitus
Ref.
Fracture site
Risk effect (95%CI)
P value
Risk factors (site)
Vilaca et al[39], 2020HipRR 1.33 (1.19-1.49)SYounger age, female gender, insulin use, longer duration of diabetes (hip)
Nonvertebral RR 1.19 (1.11-1.28)S
Koromani et al[43], 2020Vertebral (incident)OR 1.35(1.27-1.44)S
Vertebral (prevalent)OR 0.84 (0.74-0.95)S
Wang et al[36], 2019 AllRR 1.22 (1.13-1.31)S
HipRR 1.27 (1.16-1.39)S
Distal forearmRR 0.97 (0.66-1.09)NS
Upper armRR 1.54 (1.19-1.99)S
AnkleRR 1.15 (1.01-1.31)S
VertebraeRR 1.74 (0.96-3.16)NS
Liu et al[44], 2018LimbRR 1.18 (1.02-1.35)SFemale gender (leg/ankle)
Leg/AnkleRR 1.80 (1.13-2.87)S
HumerusRR 1.27 (0.60-2.68)NS
Wrist/hand/footRR 1.26 (0.94-1.71)NS
ForearmRR 0.98 (0.78-1.23) NS
Vilaca et al[45], 20191AnkleRR 1.30 (1.15-1.48)S
WristRR 0.85 (0.77-0.95)S
Moayeri et al[37], 2017All RR 1.05 (1.04-1.06)SOlder age, male gender, duration of diabetes. Insulin use, Corticosteroid use (overall)
HipRR 1.20 (1.17-1.23)S
VertebralRR 1.16 (1.05-1.28)S
FootRR 1.37 (1.21-1.54)S
WristRR 0.98 (0.88-1.07)NS
Proximal humerusRR 1.09 (0.86-1.31)NS
AnkleRR 1.13 (0.95-1.32)NS
Jia et al[38], 20172AllIRR 1.23 (1.12-1.35)S
HipIRR 1.08 (1.02-1.15)S
VertebraeIRR 1.21 (0.98-1.48)NS
Ni and Fan[42], 2017All LBMFRR 1.24 (1.09-1.41)SFemale gender
Dytfeld and Michalak[40], 20173HipOR 1.30 (1.07-1.57)SCohort studies, Studies conducted in Asia (hip)
Vertebral OR 1.13 (0.94-1.37)NS
Fan et al[41], 2016HipRR 1.34 (1.19-1.51)S
Vestergaard[16], 2007 HipRR 1.38 (1.25-1.53)S
Wrist RR 1.19 (1.01-1.41)S
VertebraeRR 0.93 (0.63-1.37)NS
AllRR 0.96 (0.57-1.61)NS
Janghorbani et al[14], 2007 HipRR 1.7 (1.3-2.2)S